**Core Concept:** Malignant hyperthermia is a rare but potentially life-threatening complication of general anesthesia, mainly triggered by certain drugs like sugammadex, dantrolene, and rocuronium. It is characterized by a rapid rise in body temperature, increased heart rate, and acidosis. Receptor involved in this process is the calcium release channel of sarcoplasmic reticulum (RyR) in muscle cells.

**Why the Correct Answer is Right:** Malignant hyperthermia is a disorder of calcium homeostasis in skeletal muscle cells. The primary receptor involved in this condition is the ryanodine receptor (RyR), which is located on the sarcoplasmic reticulum of muscle cells. RyR is a calcium release channel that plays a crucial role in regulating the release of calcium ions from the sarcoplasmic reticulum to the cytoplasm, thereby controlling muscle contraction and relaxation.

In the case of malignant hyperthermia, the RyR channel becomes abnormally sensitive to calcium ions, leading to a rapid and uncontrolled release of calcium ions into the cytoplasm. This results in increased muscle contraction, heat production, and eventually hyperthermia, acidosis, and other symptoms of malignant hyperthermia.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because malignant hyperthermia is primarily caused by abnormal functioning of RyR receptor, not by an increase in calcium sensitivity.

B. This option is incorrect because malignant hyperthermia is a genetically-determined disorder, not a result of a decrease in muscle sensitivity to certain drugs.

C. This option is incorrect because malignant hyperthermia is a genetic disorder, not caused by an increase in muscle sensitivity to certain drugs, and it is unrelated to the action of sugammadex, which is a reversal agent for rocuronium and sugammadex.

D. This option is incorrect because malignant hyperthermia is a genetic disorder, not a result of increased sensitivity to dantrolene, a drug used to treat muscle spasms and hyperthermia associated with malignant hyperthermia.

**Clinical Pearl:** Malignant hyperthermia is a genetic disorder caused by mutations in the genes encoding the dihydropyridine receptor and ryanodine receptor, which are essential for proper calcium homeostasis in skeletal muscle cells. These mutations lead to an abnormally increased sensitivity of the ryanodine receptor to caffeine and halothane, causing a rapid and uncontrolled release of calcium ions, leading to malignant hyperthermia.